Management beat the quarter by draining the upgrade backlog, then guided margins down for H2 and refused to confirm growth for next year.
Thesis: ASML is a monopoly pricing like a cyclical. The 'Beat and Raise' narrative has broken against the reality of H2 margin compression (53.7% -> 50-52%) and backlog adjustments (EUR 1.4B negative). Management's refusal to confirm 2026 growth explicitly de-risks the 2030 target by pushing the ramp out. You are paying 35x for 'lumpy' bookings and significant tariff exposure. The upgrade cycle that padded H1 margins is ending, and the High NA transition is dilutive.
Verdict: AVOID — Conviction: MEDIUM
Catalyst: Q3 bookings print. If they don't accelerate to cover the EUR 30B+ revenue target for 2026, the growth narrative breaks.
Key Risk: China export controls tightening further. China is 25% of revenue and 'adjusting' in the backlog. Loss of this floor would be catastrophic.
The Tell: CFO Roger Dassen stating: 'bookings are lumpy, because we believe bookings are not necessarily a good reflection of the business momentum.' He is explicitly telling you the order book—the primary forward indicator—is unreliable.
Friction Level: HIGH_FRICTION — Bulls see a temporary pause before the 2026 ramp. Bears see structural margin dilution and a backlog that requires 'adjustments' to stay healthy.
Report not found
The report data is no longer available. Please return to the archive.